Positions

Selected Publications

Academic Article

Year Title Altmetric
2021 Spironolactone reduces aortic stiffness in patients with resistant hypertension independent of blood pressure change.  Journal of the American Heart Association.  10. 2021
2021 Masked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone Secretion.  Hypertension.  77:435-444. 2021
2021 Uric Acid Is Not Associated with Blood Pressure Phenotypes and Target Organ Damage According to Blood Pressure Phenotypes.  American Journal of Hypertension.  34:64-72. 2021
2020 In response.  Annals of Internal Medicine.  173:683. 2020
2020 Case of Episodic and Positional Hypertension: Diagnosis and Treatment.  Hypertension.  76:614-621. 2020
2020 Reserpine substantially lowers blood pressure in patients with refractory hypertension: A proof-of-concept study.  American Journal of Hypertension.  33:741-747. 2020
2020 The unrecognized prevalence of primary aldosteronism a cross-sectional study.  Annals of Internal Medicine.  173:10-20. 2020
2020 Aortic blood pressure and arterial stiffness in patients with controlled resistant and non-resistant hypertension.  Journal of Clinical Hypertension.  22:167-173. 2020
2020 Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension.  Hypertension.  510-515. 2020
2019 Masked uncontrolled hypertension is not attributable to medication nonadherence.  Hypertension.  74:652-659. 2019
2019 Blood Pressure Measurement Challenges in Severely Obese Patients.  American Journal of Hypertension.  32:139-140. 2019
2019 Out-of-Clinic Sympathetic Activity Is Increased in Patients with Masked Uncontrolled Hypertension.  Hypertension.  73:132-141. 2019
2018 Case of refractory hypertension controlled after aortic and mitral valve replacement and coronary artery bypass grafting.  Hypertension.  72:3-9. 2018
2018 Refractory hypertension is not attributable to intravascular fluid retention as determined by intracardiac volumes.  Hypertension.  72:343-349. 2018
2017 Refractory versus resistant hypertension: Novel distinctive phenotypes..  Journal of nature and science.  3. 2017
2017 White-Coat Effect Is Uncommon in Patients with Refractory Hypertension.  Hypertension.  70:645-651. 2017
2017 11-beta dehydrogenase type 2 activity is not reduced in treatment resistant hypertension.  American Journal of Hypertension.  30:518-523. 2017
2017 Refractory versus resistant hypertension.  Current Opinion in Nephrology and Hypertension.  26:14-19. 2017
2016 Nicotinic receptors in chronic kidney disease.  Neurotransmitter.  2016
2016 Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement.  Journal of the American Society of Hypertension.  10:493-499. 2016
2016 Refractory hypertension: A novel phenotype of antihypertensive treatment failure.  Hypertension.  67:1085-1092. 2016
2016 Resistant and Refractory Hypertension: Antihypertensive Treatment Resistance vs Treatment Failure.  Canadian Journal of Cardiology.  32:603-606. 2016
2014 A survey of primary care resident attitudes toward continuity clinic patient handover..  Journal of Community Hospital Internal Medicine Perspectives.  4:25087. 2014

Education And Training

  • Bachelor of Medicine & Surgery (MBBS), 2010

    • Full Name

  • Mohammed Siddiqui